Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV004592203 | SCV005081460 | uncertain significance | not provided | 2023-08-17 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Ambry Genetics | RCV004867935 | SCV005513949 | uncertain significance | not specified | 2024-11-10 | criteria provided, single submitter | clinical testing | The c.1543G>A (p.A515T) alteration is located in exon 10 (coding exon 9) of the ATP2B2 gene. This alteration results from a G to A substitution at nucleotide position 1543, causing the alanine (A) at amino acid position 515 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |